Tenax Therapeutics, Inc. (TENX)

NASDAQ: TENX · IEX Real-Time Price · USD

3.560

+0.030 (0.85%)

At close: Apr 24, 2024, 4:00 PM

3.460

-0.100 (-2.81%)

Pre-market: Apr 25, 2024, 8:35 AM EDT

Tenax Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2000
Net Income	-7.71	-11.05	-32.47	-9.85	-8.39	-14.14	-8.84	-43.92	-14.08	-25.35	Upgrade
Depreciation & Amortization	0.01	0.11	0.11	0.11	0.11	0.01	0.01	0.02	0.15	0.15	Upgrade
Share-Based Compensation	0.19	0.37	0.77	0.35	0.27	0.61	0.58	0.53	0.89	8.69	Upgrade
Other Operating Activities	1.61	-0.82	20.74	0.11	0.46	8.03	-3.89	27.5	3.3	1.44	Upgrade
Operating Cash Flow	-5.9	-11.39	-10.86	-9.27	-7.56	-5.5	-12.14	-15.87	-9.75	-9.26	Upgrade
Capital Expenditures	0	-0	-0.01	-0	-0	-0.01	-0	0.07	0	-0.01	Upgrade
Change in Investments	0	0	0.46	0.02	0	7.36	3.75	22.13	-40.82	0	Upgrade
Other Investing Activities	-	-	-	-	-	-	-	-	-0.11	-0.14	Upgrade
Investing Cash Flow	0	-0	0.45	0.02	-0	7.35	3.75	22.21	-40.93	-0.15	Upgrade
Share Issuance / Repurchase	14.19	7.93	9.74	10.35	0.1	0	0	0	0.54	62.04	Upgrade
Debt Issued / Paid	-0.62	0	0	0.24	0	0	0	0	-0.26	0.01	Upgrade
Other Financing Activities	-	-	-	-	-	8.91	-	-	-	4.9	Upgrade
Financing Cash Flow	13.57	7.93	9.74	10.6	0.1	8.91	0	0	0.28	66.95	Upgrade
Net Cash Flow	7.67	-3.46	-0.67	1.34	-7.46	10.76	-8.39	6.34	-50.39	57.54	Upgrade
Free Cash Flow	-5.9	-11.39	-10.86	-9.28	-7.56	-5.51	-12.15	-15.8	-9.75	-9.27	Upgrade
Free Cash Flow Margin	-	-	-	-	-	-	-	-	-19775.45%	-3211.13%	Upgrade
Free Cash Flow Per Share	-23.75	-619.37	-844.54	-1431.84	-1952.34	-5631.03	-13775.46	-17979.26	-11107.97	-31690.18	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).